Patents by Inventor Melanie Taziaux

Melanie Taziaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and their uses for alleviating menopause-associated symptoms
    Patent number: 11666585
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: June 6, 2023
    Assignee: ESTETRA SRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20230073911
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: October 24, 2022
    Publication date: March 9, 2023
    Applicant: ESTETRA SRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20230050253
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: October 11, 2022
    Publication date: February 16, 2023
    Applicant: ESTETRA SPRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20230031329
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: August 23, 2022
    Publication date: February 2, 2023
    Applicant: ESTETRA SRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20230025785
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at a specific daily dose, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: August 31, 2022
    Publication date: January 26, 2023
    Applicant: ESTETRA SRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • Compounds and their uses for alleviating menopause-associated symptoms
    Patent number: 11484539
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at a specific daily dose, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: November 1, 2022
    Assignee: Estetra SPRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • Compounds and their uses for alleviating menopause-associated symptoms
    Patent number: 11452733
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: September 27, 2022
    Assignee: Estetra SPRL
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20210154212
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at a specific daily dose, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: April 19, 2019
    Publication date: May 27, 2021
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet
  • COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
    Publication number: 20210154211
    Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.
    Type: Application
    Filed: April 19, 2019
    Publication date: May 27, 2021
    Inventors: Melanie Taziaux, Glwadys Rausin, Maud Jost, Marie Mawet